Help Patients Start Strong and Stay on Therapy
Our clinicians specialize in the conditions they support, so they catch what others might miss.
We pair that expertise with adherence data to flag risk early and keep patients on track.
Clinical Expertise Matched to the Condition.
Depending on the program, patients are supported by case managers or clinical case managers who know the condition well. When a therapy calls for it, specialized clinicians join them, such as dietitians, physical therapists, or disease-specific nurses.
From the first conversation, we explain what therapy involves and what success looks like, helping patients start informed and address unexpected challenges that can lead them to stop treatment.
Predicting Non-Adherence Before It Happens
Most adherence problems show warning signs before a patient misses a dose. We use adherence data models to flag those signs early, then route the right clinical outreach to the patient before a gap becomes a pattern.
When a barrier does surface, whether it's side effects, cost, or uncertainty about why a medication matters, our clinicians address it directly.
Evidence That Grows With Every Patient
Every patient relationship we build also strengthens the evidence behind your product. Our registry infrastructure captures real-world outcomes that can support label expansion and inform how future patients are supported.
Success Stories
Clinical Navigators Help Infusion Start Completion Triple
How dedicated PRO-spectus clinical navigators raised infusion starts from 20% to over 70% of patients and lifted adherence from 10% to a steady 86%.
Read Article
Patient Access, Built Around Every Patient and Every Case
What makes your clinical team different from a general nurse navigator model?
Our clinicians are matched to the specific therapeutic area they support, registered dietitians, physical therapists, and disease-specific nurses, rather than one general nurse navigator handling every condition. That specialization lets them interpret clinical notes and patient-specific barriers with more depth.
How do you identify patients at risk of falling off therapy?
We use adherence data models that flag early indicators of non-adherence, so outreach happens before a missed dose becomes a pattern, not after.
What happens when a patient reports a barrier to staying on therapy?
Our clinicians address it directly, whether that means working through a cost barrier, managing a side effect, or clarifying why a medication matters, so the conversation leads to a resolution instead of just a note in the file.
How is patient registry data used?
Registry data captures real-world outcomes that can support label expansion and inform how future patients on the same therapy are supported. It's built on the relationships our clinicians already have with the patients in their care.
Does this replace what a patient's prescriber or care team does?
No. Our clinical team works alongside a patient's prescriber and care team, focusing on education, adherence, and barrier resolution, while clinical decisions remain with the treating provider.
